{{Rsnum
|rsid=2072797
|Gene=SUN2
|Chromosome=22
|position=38738202
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.1134
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SUN2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 17.7 | 2.7
| HCB | 66.4 | 29.9 | 3.6
| JPT | 76.1 | 23.0 | 0.9
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 66.4 | 29.9 | 3.6
| CHD | 67.9 | 27.5 | 4.6
| GIH | 84.2 | 13.9 | 2.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 84.5 | 15.5 | 0.0
| MKK | 92.9 | 6.4 | 0.6
| TSI | 73.5 | 25.5 | 1.0
| HapMapRevision=28
}}
[[rs2072797]], a SNP in the [[SUN2]] gene also known as G671S, is associated with risk for developing [[Non-Hodgkin Lymphoma]] based on a study of 458 patients. The odds ratio is 1.50 (CI: 1.12-2.00, p<0.01). {{PMID|17827388|OA=1
}}

{{GET Evidence
|gene=SUN2
|aa_change=Gly671Ser
|aa_change_short=G671S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2072797
|overall_frequency_n=878
|overall_frequency_d=10758
|overall_frequency=0.0816137
|n_genomes=6
|n_genomes_annotated=0
|n_haplomes=7
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.982
|nblosum100=2
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}